Targeted radiation for prostate cancer that came back
Part of Cancer, Kidney & urinary clinical trials.
This study tests a focused (“salvage”) brachytherapy—radiation placed directly near the prostate—to treat prostate cancer that has returned after earlier radiation. It may help control the tumor while limiting radiation exposure to surrounding tissues, based on how well people fit the study’s safety and cancer details.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your prostate cancer must be confirmed by biopsy as a recurrence after you had prior radiation treatment
- Your cancer return must look localized on scans (MRI; or if MRI isn’t possible, TRUS plus CT), with no signs of spread to other organs
- Your PSA blood test results must be less than 10 ng/mL, and your PSA should rise slowly (PSA doubling time over 6 months)
- You should not have taken anti-androgen hormone therapy in the past year
- You must have urinary symptoms from prostate cancer that are not too severe (IPSS/dysuria score 20 or less) and be well enough for study procedures (WHO health score 2 or less)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies high-dose radiation (HDR) given after prostate cancer returns only in the prostate/seminal vesicles. It may help by trying to control the cancer when it has not spread elsewhere, using targeted treatment based on MRI and biopsy proof.
This trial tests a high-dose radiation treatment (brachytherapy) that places tiny radioactive seeds directly into the area where your prostate was. It is for men whose prostate cancer has returned only in that area after having their prostate removed.
This trial tests a new way to use a type of internal radiation (high-dose-rate brachytherapy) guided by MRI to treat prostate cancer that has come back in the same area after previous radiation therapy. It is designed to be more precise and hopefully safer while using the latest PSMA PET scans to make sure the cancer hasn't spread.
This trial tests a focused form of radiation placed inside the prostate to treat only the cancer area in people with low-risk prostate cancer. It aims to control the cancer while limiting treatment to a smaller area.
This study looks at whether re-treating prostate cancer with radiation (after it came back) can be done safely and how side effects affect people. It also checks whether this approach is practical to carry out, especially for urinary side effects and comfort during the process.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.